Staff turnover in EUR704.422875.525789.240812.715862.917
Staff turnover in EUR704.422875.525789.240812.715862.917
Die Aktie: Angaben in EURO20212022202320242025
Aktien im Umlauf (in Mio.)73.202,0073.202,0073.202,001.645,7773.202,00
Dividende pro Aktie76788098125
unverwässertes Ergebnis pro Aktie184,29227,64197,83235,39263,73
GuV in Mio. EURO nach IAS/IFRS20212022202320242025
Umsatz999.758,01.259.946,01.111.367,01.170.611,01.257.941,0
Operatives Ergebnis (EBIT)2.264,02.867,62.387,52.918,53.207,3
Ergebnis vor Steuer (EBT)419.385,0531.166,0443.821,0543.034,0597.807,0
Annual net profit/ loss302.995,0374.429,0325.472,0387.317,0434.012,0
Bilanz in Mio. EURO nach IAS/IFRS20212022202320242025
Aktiva
Summe Umlaufvermögen1.063.661,01.336.537,01.366.426,01.606.043,01.740.758,0
Summe Anlagevermögen475.033,0533.221,0566.121,0602.330,0727.837,0
Summe Aktiva1.538.694,01.869.758,01.932.547,02.208.373,02.468.595,0
Passiva
Summe kurzfristige Verbindlichkeiten327.422,0423.730,0288.217,0290.357,0411.077,0
Summe langfristige Verbindlichkeiten23.255,021.641,018.749,016.517,031.784,0
Summe Rückstellungen5.046,06.067,05.739,06.123,08.855,0
Summe Eigenkapital1.188.017,01.424.387,01.625.580,01.901.499,02.025.732,0
Summe Passiva1.538.694,01.869.758,01.932.547,02.208.373,02.468.595,0
Management:
Osamu Okuda
Hitoshi Ikura
Kaori Ouchi
Iwaaki Taniguchi
Norihisa Onozawa
Shinji Hidaka
Shoko Kimijima
Tsukasa Kusano
Yoshiyuki Yano
Aufsichtsrat:
Hitoshi Iikura
Thomas Schinecker
Boris El Zaitla
Fumio Tateishi
Hideo Teramoto
Iwaaki Taniguchi
Kinuko Mitani
Theresa Graham
Aktionärsstruktur in %:
Adresse: Nihonbashi Mitsui Tower, 15/F, 2-1-1 Nihonbashi-Muromachi, 103-8324 Tokyo
T: +81-3-3281-6611
F: +81-3-3281-6607
I: https://www.chugai-pharm.co.jp
E: